This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
McKesson (MCK) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
McKesson (MCK) concluded the recent trading session at $585.08, signifying a +0.57% move from its prior day's close.
Should Value Investors Buy CONMED (CNMD) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
McKesson (MCK) Gains As Market Dips: What You Should Know
by Zacks Equity Research
McKesson (MCK) concluded the recent trading session at $585.24, signifying a +0.83% move from its prior day's close.
Pro-Dex Stock Skyrockets Over the Past Year: A Must Buy?
by Zacks Equity Research
Investors can consider investing in PDEX right now as the stock has done extremely well through 2024 and its prospects continue to shine.
McKesson Stock Declines Post Divestiture of Canada-Based Businesses
by Zacks Equity Research
MCK aims to focus on capital deployment and prioritize investments to strengthen its strategic oncology and biopharma growth platforms.
Why McKesson (MCK) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
5 Beaten-Down MedTech Stocks Set to Rebound in 2025
by Moumi Mondal
Investors may want to take a closer look at discounted stocks, such as MCK, HAE, ARAY, LIVN and PBH, in the present market landscape.
Is Xtrackers Russell US Multifactor ETF (DEUS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DEUS
Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
by Zacks Equity Research
McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Should Xtrackers Russell US Multifactor ETF (DEUS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DEUS
Vistra and Vera Bradley have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Vistra and Vera Bradley are part of the Zacks Bull and Bear of the Day article.
The Zacks Analyst Blog Highlights Leidos, First American Financial, McKesson, The Gap and SkyWest
by Zacks Equity Research
Leidos, First American Financial, McKesson, The Gap and SkyWest are part of the Zacks top Analyst Blog.
Are Investors Undervaluing McKesson (MCK) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
A Christmas Holiday Trading Week: Global Week Ahead
by John Blank
With a four-day trading week, and a major Western holiday, don't expect much to stir U.S. or global share markets in terms of macro data.
4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025
by Sridatri Sarkar
Investing in large-cap MedTech stocks like MCK, PEN, CAH and PEN can be profitable for investors in 2025.
Best Growth Stocks to Buy for December 20th
by Zacks Equity Research
GBX, STRL and MCK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 20, 2024
Buy 5 Value Stocks Amid Strong Upside Potential in the Short Term
by Nalak Das
Five value stocks have strong revenues and earnings potential in 2025. These are: FAF, MCK, LDOS, SKYW, GAP.
Zacks Investment Ideas feature highlights: Gulfport Energy, McKesson and Marvell
by Zacks Equity Research
Gulfport Energy, McKesson and Marvell have been highlighted in this Investment Ideas article.
3 Top Ranked Stocks to Buy for 2025 (GPOR, MCK, MRVL)
by Ethan Feller
Gulfport Energy, McKesson and Marvell Technology offer broad exposure to the market improving returns during periods of uncertainty
Best Growth Stocks to Buy for December 19th
by Zacks Equity Research
TWLO, MCK and ZIM made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 19, 2024
Best Growth Stocks to Buy for December 18th
by Zacks Equity Research
MCK, GBX and LTM made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 18, 2024
Best Value Stocks to Buy for December 18th
by Zacks Equity Research
LTM, BBAR and MCK made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 18, 2024.
Reasons to Add McKesson Stock to Your Portfolio Right Now
by Zacks Equity Research
MCK's strategic collaborations and strength in Biologics raise optimism about the stock.
The Zacks Analyst Blog Highlights McKesson, Doximity and Veracyte
by Zacks Equity Research
McKesson, Doximity and Veracyte are included in this Analyst Blog.